아시아태평양의 바이오제조 바이러스 검출 및 정량화 시장 : 분석과 예측(2023-2032년)

Asia-Pacific Biomanufacturing Viral Detection and Quantification Market: Analysis and Forecast, 2023-2032

US $ 2,950 ￦ 4,259,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,450 ￦ 6,424,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

아시아태평양의 바이오제조 바이러스 검출 및 정량화 시장 : 서론

주요 시장 통계
예측 기간	2023-2032년
2023년 평가	1억 1,000만 달러
2032년 예측	2억 8,000만 달러
CAGR	10.47%

아시아태평양의 바이오제조 바이러스 검출 및 정량화 시장 규모는 2023년 1억 1,000만 달러에서 예측 기간 중 10.47%의 CAGR로 추이하며, 2032년에는 2억 8,000만 달러 규모로 성장할 것으로 예측됩니다.

이 시장의 성장은 바이오의약품의 사용 증가와 업계에서 바이러스 검사 기술의 진보에 의해 추진될 것으로 예측됩니다.

아시아태평양의 바이오제조 바이러스 검출 및 정량화 시장은 현재 급속한 페이스로 진전하고 있습니다. 이 성장은 이 지역에서 바이오의약품의 채택 증가에 기인하고 있습니다. 바이오의약품의 안전성, 유효성, 일관성을 확보하기 위한 강고한 품질관리 프로세스에 대한 엄격한 요구가 생물제제 제조에서 바이러스 오염물질의 정량화에 사용되는 소모품 및 기기에 대한 수요를 촉진하고 있습니다. 아시아태평양에서 바이오의약품 업계의 진보가 수용됨에 따라 바이러스 검출 및 정량화 솔루션의 수요가 급증할 전망입니다.

아시아태평양의 바이오제조 바이러스 검출 및 정량화 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인의 분석, 법규제 환경, 시장 규모의 추이·예측, 주요 국가별 상세 분석, 주요 기업의 분석 등을 정리하여 전해드립니다.

시장의 분류

세분화 1 : 제공 유형별

• 소모품
• 기기
• 서비스

세분화 2 : 기술별

• PCR법
• ELISA법
• 유세포분석
• 플라크 어세이
• 기타

세분화 3 : 용도별

• 혈액 및 혈액제제 제조
• 백신 및 치료제 제조
• 세포·유전자 치료 제품 제조
• 줄기세포 제품 제조
• 조직 및 조직 제품 제조

세분화 4 : 최종사용자별

• 생명과학 기업
• 시험 기관
• CRO 및 CDMO

세분화 5 : 국가별

• 중국
• 일본
• 한국
• 호주
• 인도
• 기타

목차

주요 요약

제1장 시장의 범위

제2장 조사 방법

제3장 시장 개요

• 개요
• 현재 시장 규모와 향후 성장 가능성

제4장 업계의 전망

• 규제 상황

제5장 바이오제조 바이러스 검출 및 정량화 시장 : 시장 역학

• 사업 촉진요인
  • 바이오의약품의 이용 확대
  • 바이러스 검출 및 정량화에서 기술의 진보
  • 영향 분석
• 사업상 제약
  • 첨단 바이러스 검출 및 정량화 장비의 고비용성
  • 바이러스 검출 및 정량화 분야에서 훈련을 받은 전문가의 부족
  • 영향 분석
• 사업 기회
  • 세포치료 및 유전자 치료의 개발에서 바이러스 오염에 대한 고려의 필요성 증대

제6장 바이오제조 바이러스 검출 및 정량화 시장 : 지역별

• 개요
• 아시아태평양
  • 제공 유형별
  • 기술별
  • 용도별
  • 최종사용자별
  • 국가별

제7장 시장 : 경쟁 벤치마킹·기업 개요

• 개요
• 기업 점유율 분석
• 에코시스템으로 활발한 기업
• TAKARA HOLDINGS INC.

KSA

영문 목차

영문목차

“The Asia-Pacific Biomanufacturing Viral Detection and Quantification Market Expected to Reach $0.28 Billion by 2032.”

Introduction to Asia-Pacific Biomanufacturing Viral Detection and Quantification Market

KEY MARKET STATISTICS
Forecast Period	2023 - 2032
2023 Evaluation	$0.11 Billion
2032 Forecast	$0.28 Billion
CAGR	10.47%

The Asia-Pacific biomanufacturing viral detection and quantification market was valued at $0.11 billion in 2023 and is anticipated to reach $0.28 billion by 2032, witnessing a CAGR of 10.47% during the forecast period 2023-2032. The biomanufacturing viral detection and quantification market growth is anticipated to be propelled by the increasing use of biopharmaceutical products and the technological advancements in viral testing within the industry.

Market Introduction

The Asia-Pacific (APAC) biomanufacturing viral detection and quantification market is currently advancing at a rapid pace. This growth can be attributed to the increasing adoption of biopharmaceuticals within the region. The stringent need for robust quality control processes to ensure the safety, efficacy, and consistency of biopharmaceutical products is driving the demand for consumables and instruments used in quantifying viral contaminants during the biomanufacturing of biologics. As APAC embraces the biopharmaceutical industry's advancements, the demand for viral detection and quantification solutions is expected to surge. This presents a significant opportunity for manufacturers and providers of biomanufacturing viral detection and quantification products in the APAC market, as they play a pivotal role in ensuring the integrity and safety of biopharmaceutical production processes in the region.

Market Segmentation:

Segmentation 1: by Offering Type

• Consumables
• Instruments
• Services

Segmentation 2: by Technology

• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others

Segmentation 3: by Application

• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

• Life Science Companies
• Testing Laboratories
• CROs and CDMOs

Segmentation 5: by Country

• China
• Japan
• South Korea
• Australia
• India
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the APAC biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Table of Contents

Executive Summary

1. Market Scope

• 1.1. Key Questions Answered in the Report

2. Research Methodology

3. Market Overview

• 3.1. Overview
• 3.2. Current Market Size and Future Growth Potential, $Billion, 2022-2032

4. Industry Outlook

• 4.1. Regulatory Landscape
  • 4.1.1. Legal Requirements and Frameworks in Asia-Pacific
    • 4.1.1.1. Legal Requirements and Framework in Japan

5. Biomanufacturing Viral Detection and Quantification Market: Market Dynamics

• 5.1. Business Drivers
  • 5.1.1. Increasing Utilization of Biopharmaceuticals
  • 5.1.2. Technological Advancements in Viral Detection and Quantification
  • 5.1.3. Impact Analysis
• 5.2. Business Restraints
  • 5.2.1. High Cost of Advanced Viral Detection and Quantification Equipment
  • 5.2.2. Lack of Trained Professionals in the Field of Viral Detection and Quantification
  • 5.2.3. Impact Analysis
• 5.3. Business Opportunities
  • 5.3.1. Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

6. Biomanufacturing Viral Detection and Quantification Market (by Region), Value ($Million), 2022-2032

• 6.1. Overview
• 6.2. Asia-Pacific
  • 6.2.1. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
  • 6.2.2. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
  • 6.2.3. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
  • 6.2.4. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 6.2.5. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Country)
    • 6.2.5.1. China
      • 6.2.5.1.1. China Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.1.2. China Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.1.3. China Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.1.4. China Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.2. Japan
      • 6.2.5.2.1. Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.2.2. Japan Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.2.3. Japan Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.2.4. Japan Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.3. India
      • 6.2.5.3.1. India Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.3.2. India Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.3.3. India Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.3.4. India Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.4. Australia
      • 6.2.5.4.1. Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.4.2. Australia Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.4.3. Australia Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.4.4. Australia Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.5. South Korea
      • 6.2.5.5.1. South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.5.2. South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.5.3. South Korea Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.5.4. South Korea Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.6. Rest-of-Asia-Pacific
      • 6.2.5.6.1. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.6.2. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.6.3. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.6.4. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)

7. Markets - Competitive Benchmarking & Company Profiles

• 7.1. Overview
• 7.2. Company Share Analysis
• 7.3. Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
• 7.4. TAKARA HOLDINGS INC.
  • 7.4.1. Company Overview
  • 7.4.2. Role of TAKARA HOLDINGS INC. in the Biomanufacturing Viral Detection and Quantification Market
  • 7.4.3. Key Competitors
  • 7.4.4. Financials
  • 7.4.5. Key Insights about the Financial Health of the Company
  • 7.4.6. Analyst Perspective

관련자료